Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Clin Biochem ; 120: 110645, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37696320

RESUMO

BACKGROUND AND AIMS: Human epididymal protein 4 (HE4) may be a useful tool in the differential diagnosis of malignant ascites. The aim of this study was to evaluate the diagnostic utility of HE4 for detecting malignant ascites, taking into account the possible false positives identified with adenosine deaminase (ADA), C-reactive protein (CRP), % polynuclear cells (%PMN) and glomerular filtration rate (eGFR). METHODS: Concentrations of HE4, ADA, %PMN and CRP were determined in 114 samples of peritoneal fluid and creatinine in serum in order to calculate eGFR. RESULTS: Concentrations of HE4 presented significant differences (P = 0.028) in benign [median (interquartile range)] [582(372)] pmol/L) and malignant ascites ([8241(367)] pmol/L. Sensitivity was 21.2% and specificity 100%. Significant differences were also observed for HE4 between tumors of gynecological origin ([3165(8769)] pmol/L) and others ([665(663)] pmol/L), with a sensitivity of 67% and a specificity of 100%. Classifying according to possible false positives (ADA > 45U/L, CRP > 50 mg/L, %PMN > 90 and eGFR < 30 mL/min/1.73 m2) at maximum specificity, a sensitivity of 33.3% was obtained for HE4, with a cut-off point of 2660 pmol/L. Without possible false positives (ADA < 45U/L, CRP < 50 mg/L, %PMN < 90 and eGFR ≥ 30 mL/min/1.73 m2), a sensitivity of 37.7% was obtained at 100% specificity for a cut-off point of 1041 pmol/L. Applying these criteria to the entire group, a sensitivity of 36.4% was obtained at maximum specificity. CONCLUSIONS: HE4 allows the identification of malignant ascites with moderate sensitivity at maximum specificity. HE4 levels can differentiate between tumors of gynecological origin and others. Classification according to possible false positives increases sensitivity without losing specificity.

3.
Rheumatology (Oxford) ; 59(6): 1306-1314, 2020 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-31580459

RESUMO

OBJECTIVES: To compare clinical features, laboratory data and fetal-maternal outcomes between 1000 women with obstetric APS (OAPS) and 640 with aPL-related obstetric complications not fulfilling Sydney criteria (non-criteria OAPS, NC-OAPS). METHODS: This was a retrospective and prospective multicentre study from the European Registry on Obstetric Antiphospholipid Syndrome. RESULTS: A total of 1650 women with 5251 episodes, 3601 of which were historical and 1650 latest episodes, were included. Altogether, 1000 cases (OAPS group) fulfilled the Sydney classification criteria and 650 (NC-OAPS group) did not. Ten NC-OAPS cases were excluded for presenting thrombosis during follow-up. All cases were classified as category I (triple positivity or double positivity for aPL) or category II (simple positivity). Overall, aPL laboratory categories showed significant differences: 29.20% in OAPS vs 17.96% in NC-OAPS (P < 0.0001) for category I, and 70.8% in OAPS vs 82% in NC-OAPS (P < 0.0001) for category II. Significant differences were observed when current obstetric complications were compared (P < 0.001). However, major differences between groups were not observed in treatment rates, livebirths and thrombotic complications. In the NC-OAPS group, 176/640 (27.5%) did not fulfil Sydney clinical criteria (subgroup A), 175/640 (27.34%) had a low titre and/or non-persistent aPL positivity but did meet the clinical criteria (subgroup B) and 289/640 (45.15%) had a high aPL titre but did not fulfil Sydney clinical criteria (subgroup C). CONCLUSION: Significant clinical and laboratory differences were found between groups. Fetal-maternal outcomes were similar in both groups when treated. These results suggest that we could improve our clinical practice with better understanding of NC-OAPS patients.


Assuntos
Síndrome Antifosfolipídica/diagnóstico , Aspirina/uso terapêutico , Complicações na Gravidez/diagnóstico , Adulto , Anticorpos Antifosfolipídeos , Síndrome Antifosfolipídica/tratamento farmacológico , Feminino , Humanos , Nascido Vivo , Gravidez , Complicações na Gravidez/tratamento farmacológico , Resultado da Gravidez , Estudos Prospectivos , Sistema de Registros , Estudos Retrospectivos , Resultado do Tratamento
6.
Autoimmun Rev ; 18(4): 406-414, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30772493

RESUMO

AIM: To analyse the clinical features, laboratory data and foetal-maternal outcomes, and follow them up on a cohort of 1000 women with obstetric antiphospholipid syndrome (OAPS). METHODS: The European Registry of OAPS became a registry within the framework of the European Forum on Antiphospholipid Antibody projects and was placed on a website in June 2010. Thirty hospitals throughout Europe have collaborated to carry out this registry. Cases with obstetric complaints related to antiphospholipid antibodies (aPL) who tested positive for aPL at least twice were included prospectively and retrospectively. The seven-year survey results are reported. RESULTS: 1000 women with 3553 episodes were included of which 2553 were historical and 1000 were latest episodes. All cases fulfilled the Sydney classification criteria. According to the laboratory categories, 292 (29.2%) were in category I, 357 (35.7%) in IIa, 224 (22.4%) in IIb and 127 (12.7%) in IIc. Miscarriages were the most prevalent clinical manifestation in 386 cases (38.6%). Moreover, the presence of early preeclampsia (PE) and early foetal growth restriction (FGR) appeared in 181 (18.1%) and 161 (16.1%), respectively. In this series, 448 (44.8%) women received the recommended OAPS treatment. Patients with recommended treatment had a good live-birth rate (85%), but worse results (72.4%) were obtained in patients with any treatment (low-dose aspirin (LDA) or low-molecular-weight heparin (LMWH) not on recommended schedule, while patients with no treatment showed a poor birth rate (49.6%). CONCLUSION: In this series, recurrent miscarriage is the most frequent poor outcome. To avoid false-negative diagnoses, all laboratory category subsets were needed. OAPS cases have very good foetal-maternal outcomes when treated. Results suggest that we were able to improve our clinical practice to offer better treatment and outcomes to OAPS patients.


Assuntos
Síndrome Antifosfolipídica/epidemiologia , Complicações na Gravidez/epidemiologia , Aborto Habitual/tratamento farmacológico , Aborto Habitual/epidemiologia , Aborto Habitual/etiologia , Adulto , Anticorpos Antifosfolipídeos/imunologia , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/tratamento farmacológico , Síndrome Antifosfolipídica/imunologia , Aspirina/uso terapêutico , Estudos de Coortes , Europa (Continente)/epidemiologia , Feminino , Seguimentos , Heparina de Baixo Peso Molecular/uso terapêutico , Humanos , Recém-Nascido , Gravidez , Complicações na Gravidez/tratamento farmacológico , Complicações na Gravidez/imunologia , Resultado da Gravidez , Sistema de Registros , Estudos Retrospectivos , Adulto Jovem
7.
Emergencias ; 29(5): 306-312, 2017 10.
Artigo em Espanhol | MEDLINE | ID: mdl-29077289

RESUMO

OBJECTIVES: To analyze factors related to drug-resistant pathogens (DRPs) in community-onset pneumonia (COP) and whether previously suggested criteria are useful in our emergency-department. MATERIAL AND METHODS: Prospective 1-year study of adults coming to the emergency department for COP. We assessed the usefulness of criteria used in health-care-associated pneumonia (HCAP), as well the Shorr index, the Barthel index, and clinical suspicion of resistant pathogens. Data were analyzed by multiple logistic regression and the area under the receiver operating characteristic curve (AUC). RESULTS: We included 139 patients with a mean (SD) age of 75.9 (15.3) years; 63.3% were men. Forty-nine COP patients (35.2%) were at risk for DRP-caused pneumonia according to HCAP criteria; 43 (30.9%) according to the Shorr index, and 56 (40.3%) according to the Aliberti index. A score of less than 60 derived from the Barthel index was recorded for 25 patients (18%). Clinical suspicion of a DRP was recorded for 11 (7.9%). A DRP was isolated in 5 patients (3.6%) (3, Pseudomonas aeruginosa; 2, methicillin-resistant Staphylococcus aureus). Multiple logistic regression analysis identified 2 predictors of DRP-caused COP: hospital admission within the last 90 days (odds ratio [OR], 8.92; 95% CI, 1.92-41.45) and initial arterial blood oxygen saturation (OR, 0.85; 95% CI, 0.74-0.98). The AUC was 0.91 (95% CI, 0.85-0.98). The model identified 22 patients (16.8%) at risk for DRP-caused pneumonia. The positive and negative predictive values were 20% and 99.1%, respectively, for the model 90-day period (vs 8.7% and 98.9%, respectively, for criteria used in HCAP). CONCLUSION: Hospitalization within the 90-day period before a COP emergency and arterial blood oxygen saturation were good predictors of DRP in our setting. Criteria of DRP in HCAP, on the other hand, had lower ability to identify patients at risk in COP.


OBJETIVO: Analizar en las neumonías de la comunidad diagnosticados en nuestro centro los predictores de etiología por patógenos resistentes (PR) y evaluar la utilidad de distintos criterios de riesgo de PR previamente sugeridos. METODO: Se estudiaron prospectivamente durante 1 año los pacientes adultos procedentes de la comunidad atendidos en el servicio de urgencias (SU) por neumonía. Se evaluaron los criterios definitorios de neumonía asociada al cuidado sanitario (NACS), así como los índices de Shorr, Aliberti y Barthel y el juicio clínico de PR. Se realizó regresión logística múltiple y se calculó el área bajo la curva receptor-operador (ABC-ROC). RESULTADOS: Se incluyeron 139 pacientes con una edad media de 75 (DE: 15,3) años, el 63,3% varones. Tenían riesgo de PR según los criterios de NACS 49 (35,2%), según el índice de Shorr 43 (30,9%) y según índice de Aliberti 56 (40,3%). Se encontró un I. Barthel < 60 en 25 enfermos (18%) y juicio clínico de PR en 11 (7,9%). Se aisló PR en el 3,6% (3 Pseudomonas aeruginosa y 2 Staphylococcus aureus meticilin resistentes). En el análisis multivariado fueron predictores de PR el haber ingresado en los 90 días previos, con una odds ratio (OR) de 8,92 [intervalo de confianza (IC) 95%: 1,92-41,45], y la saturación inicial de oxígeno, con una OR de 0,85 [IC 95%: 0,74-0,98] con ABC-ROC de 0,91 (IC 95%: 0,85-0,98). Nuestro modelo identificó 22 pacientes (16,8%) con riesgo de PR, con valor predictivo positivo y negativo del 20% y 99,1%, respectivamente, frente a un 8,7% y 98,9%, respectivamente para NACS. CONCLUSIONES: En las neumonías de nuestro centro el antecedente de ingreso en los 90 días previos junto con la saturación de oxígeno fueron buenos predictores de PR, mientras que los criterios de NACS tuvieron menor capacidad de discriminación.


Assuntos
Infecções Comunitárias Adquiridas/microbiologia , Farmacorresistência Bacteriana , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Pneumonia Bacteriana/microbiologia , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/isolamento & purificação , Infecções Estafilocócicas/microbiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Área Sob a Curva , Infecções Comunitárias Adquiridas/diagnóstico , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/microbiologia , Serviço Hospitalar de Emergência , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/diagnóstico , Estudos Prospectivos , Infecções por Pseudomonas/diagnóstico , Curva ROC , Medição de Risco , Fatores de Risco , Infecções Estafilocócicas/diagnóstico , Adulto Jovem
8.
Emergencias (St. Vicenç dels Horts) ; 29(5): 306-312, oct. 2017. graf, tab
Artigo em Espanhol | IBECS | ID: ibc-167920

RESUMO

Objetivos. Analizar en las neumonías de la comunidad diagnosticados en nuestro centro los predictores de etiología por patógenos resistentes (PR) y evaluar la utilidad de distintos criterios de riesgo de PR previamente sugeridos. Método. Se estudiaron prospectivamente durante 1 año los pacientes adultos procedentes de la comunidad atendidos en el servicio de urgencias (SU) por neumonía. Se evaluaron los criterios definitorios de neumonía asociada al cuidado sanitario (NACS), así como los índices de Shorr, Aliberti y Barthel y el juicio clínico de PR. Se realizó regresión logística múltiple y se calculó el área bajo la curva receptor-operador (ABC-ROC). Resultados. Se incluyeron 139 pacientes con una edad media de 75 (DE: 15,3) años, el 63,3% varones. Tenían riesgo de PR según los criterios de NACS 49 (35,2%), según el índice de Shorr 43 (30,9%) y según índice de Aliberti 56 (40,3%). Se encontró un I. Barthel < 60 en 25 enfermos (18%) y juicio clínico de PR en 11 (7,9%). Se aisló PR en el 3,6% (3 Pseudomonas aeruginosa y 2 Staphylococcus aureus meticilin resistentes). En el análisis multivariado fueron predictores de PR el haber ingresado en los 90 días previos, con una odds ratio (OR) de 8,92 [intervalo de confianza (IC) 95%: 1,92-41,45], y la saturación inicial de oxígeno, con una OR de 0,85 [IC 95%: 0,74-0,98] con ABC-ROC de 0,91 (IC 95%: 0,85-0,98). Nuestro modelo identificó 22 pacientes (16,8%) con riesgo de PR, con valor predictivo positivo y negativo del 20% y 99,1%, respectivamente, frente a un 8,7% y 98,9%, respectivamente para NACS. Conclusiones. En las neumonías de nuestro centro el antecedente de ingreso en los 90 días previos junto con la saturación de oxígeno fueron buenos predictores de PR, mientras que los criterios de NACS tuvieron menor capacidad de discriminación (AU)


Objectives. To analyze factors related to drug-resistant pathogens (DRPs) in community-onset pneumonia (COP) and whether previously suggested criteria are useful in our emergency-department. Methods. Prospective 1-year study of adults coming to the emergency department for COP. We assessed the usefulness of criteria used in health-care-associated pneumonia (HCAP), as well the Shorr index, the Barthel index, and clinical suspicion of resistant pathogens. Data were analyzed by multiple logistic regression and the area under the receiver operating characteristic curve (AUC). Results. We included 139 patients with a mean (SD) age of 75.9 (15.3) years; 63.3% were men. Forty-nine COP patients (35.2%) were at risk for DRP-caused pneumonia according to HCAP criteria; 43 (30.9%) according to the Shorr index, and 56 (40.3%) according to the Aliberti index. A score of less than 60 derived from the Barthel index was recorded for 25 patients (18%). Clinical suspicion of a DRP was recorded for 11 (7.9%). A DRP was isolated in 5 patients (3.6%) (3, Pseudomonas aeruginosa; 2, methicillin-resistant Staphylococcus aureus). Multiple logistic regression analysis identified 2 predictors of DRP-caused COP: hospital admission within the last 90 days (odds ratio [OR], 8.92; 95% CI, 1.92-41.45) and initial arterial blood oxygen saturation (OR, 0.85; 95% CI, 0.74-0.98). The AUC was 0.91 (95% CI, 0.85-0.98). The model identified 22 patients (16.8%) at risk for DRP-caused pneumonia. The positive and negative predictive values were 20% and 99.1%, respectively, for the model 90-day period (vs 8.7% and 98.9%, respectively, for criteria used in HCAP). Conclusions. Hospitalization within the 90-day period before a COP emergency and arterial blood oxygen saturation were good predictors of DRP in our setting. Criteria of DRP in HCAP, on the other hand, had lower ability to identify patients at risk in COP (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Infecções Comunitárias Adquiridas/complicações , Pneumonia/epidemiologia , Assistência Ambulatorial/métodos , Fatores de Risco , Hipóxia/complicações , Radiografia Torácica , Estudos Prospectivos , Modelos Logísticos , Intervalos de Confiança , Análise Multivariada , Curva ROC
9.
s.l; Espanha. Ministerio de Sanidad, Servicios Sociales e Igualdad; 2016. ilus, tab.
Não convencional em Espanhol | BIGG - guias GRADE | ID: biblio-963998

RESUMO

Objetivos: Esta GPC sobre Enfermedad Renal Crónica (ERC) responde a preguntas clínicas concernientes a su detección precoz, derivación a atención especializada y manejo, tanto mediante tratamiento farmacológico como con medidas higiénico dietéticas, estilos de vida e intervenciones educativas. Así como informar al paciente y cuidadores para facilitar la toma de decisiones compartidas. En esta GPC no se abordan los siguientes aspectos: Tratamiento de las causas específicas o modificables de ERC, tratamiento sustitutivo renal y tratamiento de las complicaciones de la ERC (anemia, acidosis metabólica, insuficiencia cardiaca, enfermedad renal ósea, insuficiencia renal aguda). ERC en población pediátrica.


Assuntos
Humanos , Dieta com Restrição de Proteínas , Dieta Hipossódica , Insuficiência Renal Crônica/diagnóstico , Insuficiência Renal Crônica/terapia , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Ultrassonografia/métodos , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Antagonistas de Receptores de Angiotensina/uso terapêutico , Abordagem GRADE , Estilo de Vida , Anti-Hipertensivos/uso terapêutico
10.
J Med Econ ; 14(5): 628-38, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21882904

RESUMO

OBJECTIVES: The aim of this paper is to consider the relationship between the experience of pain, health related quality of life (HRQoL) and healthcare resource utilization in Spain. METHODS: The analysis contrasts the contribution of pain severity and frequency of pain reported against respondents reporting no pain in the previous month. Data are from the 2010 National Health and Wellness Survey (NHWS) for Spain. Single equation generalized linear regression models are used to evaluate the association of pain with the physical and mental component scores of the SF-12 questionnaire as well as health utilities generated from the SF-6D. In addition, the role of pain is assessed in its association with self-reported healthcare provider visits, emergency room visits and hospitalizations in the previous 6 months. RESULTS: The results indicate that the experience of pain, notably severe and frequent pain, is substantial and is significantly associated with the SF-12 physical component scores, health utilities and all aspects of healthcare resource utilization, which far outweighs the role of demographic and socioeconomic variables, health risk factors (in particular body mass index) and the presence of comorbidities. In the case of severe daily pain, the marginal contribution of the SF-12 physical component score is a deficit of -17.86 compared to those reporting no pain (population average score 46.49), while persons who are morbidly obese report a deficit of only -6.63 compared to those who are normal weight. The corresponding association with health utilities is equally dramatic with a severe daily pain deficit of -0.186 compared to those reporting no pain (average population utility 0.71). The impact of pain on healthcare resource utilization is marked. Severe daily pain increases traditional provider visits by 208.8%, emergency room visits by 373.0% and hospitalizations by 348.5%. LIMITATIONS: As an internet-based survey there is the possibility of bias towards those with internet access, although telephone sampling is used to supplement responses. Respondents are asked to describe their experience of pain; there is no independent check on the accuracy of responses. Finally, while certain acute pain categories are omitted, the study focuses on pain in the last month and not on pain chronicity. CONCLUSIONS: The societal burden of severe and frequent pain in Spain is substantial. Although not reported on before, at a national level, the deficit impact of the experience of pain far outweighs the contribution of more traditional explanations of HRQoL deficits as well as being the primary factor associated with increased provider visits, emergency room visits and hospitalizations.


Assuntos
Serviços de Saúde/estatística & dados numéricos , Dor , Qualidade de Vida , Adolescente , Adulto , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Pessoa de Meia-Idade , Espanha , Adulto Jovem
13.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 46(2): 100-110, mar.-abr. 2011. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-87997

RESUMO

La sarcopenia es un síndrome geriátrico frecuente e importante para la práctica clínica diaria de los profesionales que trabajan con personas mayores. El número de personas mayores afectadas y su relación con la incapacidad, la fragilidad, muchas enfermedades, hábitos de vida y resultados adversos son de gran relevancia para la práctica geriátrica. Además, los cambios biológicos que conducen a la pérdida de fuerza y masa muscular se relacionan intrínsecamente con los mecanismos del envejecimiento. No es, por tanto, sorprendente que la investigación en este campo esté creciendo exponencialmente en los últimos años y que la sarcopenia se haya colocado en los últimos años en el primer plano del interés geriátrico y gerontológico. La Sociedad Española de Geriatría y Gerontología ha creado recientemente un Observatorio de la Sarcopenia, que pretende promover actividades formativas y de investigación en este campo. La primera actividad del Observatorio ha sido poner a disposición de nuestra comunidad científica una revisión de la situación actual de la sarcopenia, que permita unificar conceptos y aumentar el interés en este prometedor campo de la geriatría(AU)


Sarcopenia is a common and prominent geriatric syndrome, of major interest for daily clinical practice of professionals working with older people. The number of affected individuals and its relation with disability, frailty, many chronic diseases, lifestyle and adverse outcomes are extremely relevant for geriatric care. Moreover, biological changes that lead to the loss of muscle mass and strength are intrinsically related to the mechanisms of aging. It is not therefore surprising that research in this field is growing exponentially in recent years, and sarcopenia has been placed in recent years in the forefront of research in geriatric medicine and gerontology. The Spanish Society of Geriatrics and Gerontology has recently created an Observatory of Sarcopenia, which aims to promote educational and research activities in this field. The first activity of the Observatory has been to offer the Spanish speaking scientific community a review of the current status of sarcopenia, that may allow unifying concepts and fostering interest in this promising field of geriatrics(AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Força Muscular/fisiologia , Sociedades Médicas/ética , Sociedades Médicas/normas , Envelhecimento/patologia , Músculos/fisiopatologia , Fatores de Risco , Terapia por Exercício , Exercício Físico/fisiologia , Contração Muscular/fisiologia , Sociedades Médicas/organização & administração , Sociedades Médicas/tendências , Síndrome
15.
Rev. multidiscip. gerontol ; 18(2): 68-75, abr.-jun. 2008. tab
Artigo em Espanhol | IBECS | ID: ibc-80956

RESUMO

La Nutrición enteral está indicada en los ancianos en riesgo de desnutrición o desnutridos que tienen una función intestinal adecuada. La elección de la vía de acceso estará en función del grado de ingesta, de la presencia de disfagia y del estado catabólico agudo. Los suplementos orales completos de más de 400 Kcal/día durante más de 35 días estarán indicados en todos los ancianos ingresados en el hospital mayores de 75 años y la alimentación por sonda entérica mediante preparados completos con fibra en aquellos ancianos en situación de estrés metabólico, disfagia orofaríngea irreversible o aquellos que no cubren sus necesidades por vía oral (AU)


Enteral nutrition is indicated in elderly people in risk of malnutrition or under nourished that have an appropriate intestinal function. The election of the access route will be in function of the ingesta grade, presence of disfagia and catabolic state. Complete oral supplements of more than 400 Kcal/day during more than 35 days they will be indicated in all the older adults admitted in the hospital and the feeding for enteric tubes by means of complete diet with fiber in those older patients in situation of metabolic stress, irreversible neurologic disfagia or those that don’t cover your necessities for oral route (AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Nutrição Enteral/métodos , Desnutrição/dietoterapia , Suplementos Nutricionais , Desnutrição/prevenção & controle , Doenças Metabólicas/dietoterapia , Transtornos de Deglutição/dietoterapia
17.
Rev. multidiscip. gerontol ; 17(2): 68-76, abr.-jun. 2007. tab
Artigo em Espanhol | IBECS | ID: ibc-80702

RESUMO

La nutrición parenteral (NP) está indicada como soporte nutricional especializado cunado la nutrición enteral está contraindicada o no se tolera. El acceso parenteral más apropiado es la vía venosa central. Deben realizarse en condiciones asépticas, enfermería especializada debe cuidarlos y las dosis bajas de anticoagulantes deben iniciarse en aquellos pacientes que requieran cateterización a largo plazo. Las complicaciones de la NP son costosas y graves por lo que una monitorización cuidadosa es necesaria para conseguir buenos resultados. El síndrome de realimentación (SRA) es una complicación mortal que puede aparecer durante la administración de nutrición artificial (NA), siendo los ancianos en estado marasmático crónico los de mayor riesgo. Para la utilización de NA debe conocerse las indicaciones, incluyendo beneficios y riesgos. Además, la aplicación de estas intervenciones precisa de una base moral, ética y legal que sea satisfactoria para los pacientes, familias y cuidadores. Los ancianos que reciben NP a largo plazo empeoran más que la población normal y tienen una calidad de vida relacionada con la salud igual o peor que los pacientes con insuficiencia renal crónica en diálisis(AU)


Parenteral Nutrition (PN) is appropriate when specialized nutritional support is indicated and a contraindication to use of enteral nutrition is present or enteral nutrition is not tolerated. Most appropriate parenteral access for hospitalized patients is percutaneous central venous catheters. Full-barrier precautions should be used during insertion of central lines, specialized nursing teams should care for venous access devices, and low dose anticoagulant therapy should be used in patients requiring long-term catheterization. Considerable cost and serious complications are associated with PN because regular monitoring and meticulous care are necessary to ensure successful oucomes. The refeeding syndrome (RS) is a life-threatining complication that may arise during administration of artificial nutrition (AN), at greatest risk for the RS are chronically, semistarved marasmic elderly patients. The use of AN involves understanding the medical indications, including benefits and burdens. Next, it involves applying these interventions in a moral, ethical, and legal construct that is satisfactory to patients, families, and caregivers. Elderly patients receiving long-term parenteral nutrition are worse off than normal population and have a health-related quality of life comparable or worse than those with chronic renal failure treated by dialysis(AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Nutrição Parenteral/métodos , Cateterismo Venoso Central/métodos , Distúrbios Nutricionais/terapia , Satisfação do Paciente , Fatores de Risco , Desnutrição Proteico-Calórica/terapia
18.
Rev. multidiscip. gerontol ; 17(2): 89-94, abr.-jun. 2007. tab
Artigo em Espanhol | IBECS | ID: ibc-80705

RESUMO

El diagnóstico de delirium se basa en criterios clínicos. El objetivo de este artículo es revisar el pronóstico del síndrome confusional agudo en los ancianos. La mortalidad es elevada durante el episodio agudo y a largo plazo. La mortalidad a corto plazo está relacionada con la gravedad de los síntomas y la mortalidad a largo plazo con su persistencia. Los ancianos que han sufrido delirium tienen mayor riesgo de declive cognitivo y de demencia, así como declive de la función física. Los ancianos con fractura de fémur y delirium asociado se recuperan menos y más lentamente. Todo lo expuesto favorece un elevado consumo de recursos sanitarios y sociales. Los ensayos clínicos terapéuticos deberían ir dirigidos a mejorar estos resultados teniendo en cuenta la resolución de los síntomas depresivos del delirium (AU)


Diagnosis of delirium are based on clinical approaches. The objective of this article is to revise prognosis of the syndrome among elderly people. Mortality is high during the sharp and long term episode. The short term mortality is related with symptoms severity and the long term mortality with its persistence. Elderly that have suffered delirium have bigger risk of cognitive decline and dementia, as well as decline of the physical function. Elderly with hip fracture and associate delirium recover less and more slowly. All that exposed favors a high consumption of health and social resources. Therapeutic clinical trials should go directed to improve these results keeping in mindthe resolution of the depressive symptoms of the delirium (AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Delírio/epidemiologia , Idoso Fragilizado , Confusão/complicações , Delírio/economia , Prognóstico , Estudos Prospectivos , Avaliação Geriátrica/métodos , Índice de Gravidade de Doença , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...